We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
- Authors
Adès, Lionel; Chevret, Sylvie; Raffoux, Emmanuel; de Botton, Stephane; Guerci, Agnes; Pigneux, Arnaud; Stoppa, Anne Marie; Lamy, Thierry; Rigal-Huguet, Francoise; Vekhoff, Anne; Meyer-Monard, Sandrine; Maloisel, Frederic; Deconinck, Eric; Ferrant, Augustin; Thomas, Xavier; Fegueux, Nathalie; Chomienne, Christine; Dombret, Herve; Degos, Laurent; Fenaux, Pierre; European Acute Promyelocytic Leukemia Group
- Abstract
Several phase II studies have suggested that cytarabine (AraC) was not required in the treatment of newly diagnosed acute promyelocytic leukemia (APL) patients receiving all-trans-retinoic acid (ATRA), an anthracycline, and maintenance therapy, and we aimed at confirming this finding in a randomized trial.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 36, p5703
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.08.1596